KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $19,923,000 | -28.9% | 1,141,683 | -2.4% | 0.01% | -25.0% |
| Q2 2021 | $28,031,000 | -3.7% | 1,169,600 | +3.2% | 0.01% | -7.7% |
| Q1 2021 | $29,117,000 | +855.0% | 1,133,772 | +606.4% | 0.01% | +1200.0% |
| Q4 2020 | $3,049,000 | +43.1% | 160,511 | -5.0% | 0.00% | 0.0% |
| Q3 2020 | $2,131,000 | +9.8% | 169,009 | +5.1% | 0.00% | 0.0% |
| Q2 2020 | $1,941,000 | +66.6% | 160,776 | +5.6% | 0.00% | 0.0% |
| Q1 2020 | $1,165,000 | +311.7% | 152,307 | +857.0% | 0.00% | – |
| Q4 2019 | $283,000 | – | 15,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |